Item 7.01Item 7.01 - Regulation FD Disclosure
Item 7.01. Regulation FD Disclosure.
Warrant Distribution Record Date
The Board has set a record date of the close of business on October
5, 2026 (the “Record Date”) for the Company’s previously announced distribution of warrants (“Warrants”)
to purchase shares of Class B Common Stock. The Company expects to distribute the Warrants on or about October 13, 2026 (the “Issue
Date”). The distribution of the Warrants is contingent on the closing of the previously announced acquisition by the Company of
Warner Bros. Discovery, Inc. (the “WBD Merger”); however, the WBD Merger is subject to further closing conditions, and the
ultimate timing for the closing of the WBD Merger, if any, is not yet certain. As a result, the Company may, at its discretion, choose
to cancel the Record Date and/or the Issue Date or postpone the Record Date and/or the Issue Date to a later date. If the Record Date
and/or the Issue Date is cancelled or postponed, the Company will issue a public announcement of such change in a manner that complies
with the rules of the exchange where the Company is then listed.
As previously disclosed on April 7, 2026, a special committee of the
Board that was established in connection with the Company’s approval of the WBD Merger recommended to the Board the declaration
of a distribution of Warrants to holders of Class B Common Stock as of the Record Date, excluding each of Lawrence J. Ellison, David F.
Ellison, Gerald J. Cardinale, The Lawrence J. Ellison Revocable Trust, u/a/d 1/22/88, as amended, and RedBird Capital Partners Fund IV
(Master), L.P. or any of their respective affiliates, successors or transferees (collectively, the “Restricted Holders”).
On the Issue Date, each share of Class B Common Stock held by a stockholder
as of the Record Date, other than the Restricted Holders (including any of the Company’s wholly owned subsidiaries that own Class
B Common Stock), the Paramount Global 401(k) Plan and the Paramount Global Master Trust, will receive one (1) Warrant, rounded down to
the nearest whole Warrant. The Company expects to issue approximately 470 million Warrants on the Issue Date. Shares of Class B Common
Stock held by the Paramount Global 401(k) Plan and the Paramount Global Master Trust will, in lieu of receiving Warrants in the warrant
distribution, receive shares of Class B Common Stock.
If issued, each Warrant initially will entitle the holder thereof to
purchase one (1) share of Class B Common Stock at an initial exercise price per share equal to the average of the daily volume-weighted
average price of the Class B Common Stock for the twenty (20) trading days ending on (and including) the third (3rd) business
day prior to the closing of the WBD Merger, subject to a maximum of $16.02 per share and a minimum of $12.00 per share. The exercise price
of the Warrants will be subject to certain anti-dilution and other adjustments. The Company intends to apply to list the Warrants
for trading on the NYSE, subject to applicable approvals, and the Warrants will trade separately from the Company’s Class B Common
Stock.
The Warrants will expire and cease to be exercisable at the earlier
of (i) 5:00 p.m., New York City time, on the date that is the tenth (10th) anniversary of the Issue Date or (ii) an earlier
expiration date that the Company may designate following the third (3rd) anniversary of the Issue Date, if within any period
of thirty (30) consecutive trading days following such third (3rd) anniversary, there are at least twenty (20) trading days
(whether or not consecutive), including the trading day immediately preceding the date on which the Company issues the early expiration
notice, on which the closing sale price of the Class B Common Stock is at least equal to $30.00 initially, which price will be subject
to certain anti-dilution adjustments.
This Current Report on Form 8-K does not constitute an offer to sell
or the solicitation of an offer to buy any securities, including, without limitation, the Warrants or the shares of Class B Common Stock
issuable upon exercise of the Warrants. Any offers, solicitations of offers to buy, or any sales of securities will be made in accordance
with the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”).
In connection with the declaration of the Record Date, the Company
posted a document containing questions and answers (the “Warrant Distribution FAQ”) regarding the Warrant distribution on
the Investor Relations section of the Company’s website.
The information furnished pursuant to this Item 7.01, including Exhibit
99, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange
Act”), or otherwise subject to the liabilities under that section and shall not be deemed to be incorporated by reference into any
filing under the Securities Act or the Exchange Act, except as expressly set forth by reference in such filing.
Cautionary Note Concerning Forward-Looking Statements
This communication contains “forward-looking statements”
regarding the timing and terms of any distribution of Warrants and the timing and expectations regarding the proposed listing on the NYSE
of the Class B Common Stock and Warrants. The reader is cautioned not to rely on these forward-looking statements. These statements are
based on current expectations of future events. If underlying assumptions prove inaccurate or known or unknown risks or uncertainties
materialize, actual results could vary materially from the Company’s expectations and projections. Risks and uncertainties include,
but are not limited to: the risk that the closing conditions for the WBD Merger will not be satisfied; the possibility that the WBD Merger
will not be completed in the expected timeframe or at all; damage to the Company’s reputation or brands; volatility in the price
of the Class B Common Stock and any Warrants; the effect the Company’s dual-class capital structure and the concentrated ownership
may have on the price of its Class B Common Stock; risks associated with the Company’s status as a “controlled company”
under Nasdaq rules and, following the transfer of listing described in Item 3.01 of this Current Report on Form 8-K, NYSE rules, including
its exemption from certain corporate governance requirements; and risks associated with the lack of voting rights of the Class B Common
Stock. A further list and description of these risks, uncertainties and other factors and the general risks associated with the Company
can be found in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2025, filed with the U.S. Securities
and Exchange Commission (the “SEC”) on February 25, 2026, and the Company’s Form 10-Q for the quarterly period ended
June 30, 2026, filed with the SEC on August 4, 2026, including, in each case, in the sections captioned “Cautionary Note Concerning
Forward-Looking Statements” and “Item 1A. Risk Factors,” and the Company’s subsequent filings with the SEC. Copies
of these filings, as well as subsequent filings, are available online at www.sec.gov. The Company undertakes no obligation to update any
forward-looking statement as a result of new information or future events or developments, except as required by law.